Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul-Aug;67(4):478.
doi: 10.4103/ijd.ijd_13_22.

Demographic Characteristics of the Patients with Cutaneous Vasculitis Due to COVID-19 Infection

Affiliations

Demographic Characteristics of the Patients with Cutaneous Vasculitis Due to COVID-19 Infection

Fariba Iraji et al. Indian J Dermatol. 2022 Jul-Aug.

Abstract

Background: Cutaneous manifestations of coronavirus disease 2019 (COVID-19) range from mild skin rashes to severe vasculitis. In the current study, we evaluated the demographic characteristics of the patients with cutaneous vasculitis following COVID-19 infection.

Materials and methods: In the current study, we evaluated 799 hospitalised patients with COVID-19 infection for development of cutaneous vasculitis. Demographic and clinical characteristics of the patients were obtained using questionnaires and patients' records. Cutaneous vasculitis of the suspected patients were confirmed using skin biopsy and direct immunofluorescence.

Results: We detected 24 hospitalised cases with cutaneous vasculitis presenting with petechia, purpura, livedoretcularis and acrocyanosis. Our data showed a significant relationship between male sex, advanced age, C-reactive protein (CRP) level and presence of comorbidities with development of cutaneous vasculitis. In addition, we found a positive association between the severity of COVID-19 infection and occurrence of cutaneous vasculitis.

Conclusion: Our findings are suggestive that clinicians must be aware of cutaneous vasculitis risk as prognostic value in the patients with severe COVID-19 infection.

Keywords: C-reactive protein (CRP); COVID-19; cutaneous vasculitis.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Various manifestations of the cutaneous vasculitis in COVID-19 evaluated patients

Similar articles

References

    1. Cascella M, Rajnik M, Aleem A, Dulebohn S, Di Napoli R. Features, Evaluation, and Treatment of Coronavirus (COVID-19) StatPearls; 2021. - PubMed
    1. Khalagi K, Gharibzadeh S, Khalili D, Mansournia MA, Samiee SM, Aghamohamadi S, et al. Prevalence of COVID-19 in Iran: Results of the first survey of the Iranian COVID-19 serological surveillance program. Clin Microbiol Infect. 2021;27:1666–71. - PMC - PubMed
    1. Forsblom E, Silén S, Kortela E, Ahava M, Kreivi H-R, Holmberg V, et al. Male predominance in disease severity and mortality in a low Covid-19 epidemic and low case-fatality area–A population-based registry study. Infect Dis (Lond) 2021;53:789–99. - PubMed
    1. Bian J, Li Z. Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator. Acta Pharm Sin B. 2021;11:1–12. - PMC - PubMed
    1. Jamshidi P, Hajikhani B, Mirsaeidi M, Vahidnezhad H, Dadashi M, Nasiri MJ. Skin manifestations in COVID-19 patients: Are they indicators for disease severity? A systematic review. Front Med (Lausanne) 2021;8:634208. - PMC - PubMed